- Latest Stories
- Commentary and Analysis
9:46AM ET 8/08/2022 MT Newswires(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
2:45PM ET 8/01/2022 MT NewswiresFennec Pharmaceuticals (FENC) said Monday it has secured up to $45 million in investment from private equity firm Petrichor Healthcare Capital Management....
1:55PM ET 5/12/2022 MT Newswires(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
6:12AM ET 5/12/2022 MT NewswiresFennec Pharmaceuticals (FENC) reported a Q1 net loss Thursday of $0.14 per diluted share, narrowing from a $0.18 loss a year earlier. Two analysts polled...
6:24AM ET 3/24/2022 MT NewswiresFennec Pharmaceuticals (FENC) said Thursday it has resubmitted its new drug application for Pedmark to the US Food and Drug Administration. Pedmark is a...
2:02PM ET 2/28/2022 MT Newswires(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
6:06AM ET 1/31/2022 MT NewswiresFennec Pharmaceuticals (FENC) said Monday that Chief Commercial Officer Shubh Goel has resigned and will leave the company in late February. ...
9:35AM ET 12/01/2021 MT Newswires(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
10:31AM ET 11/30/2021 MT Newswires(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
9:38AM ET 11/29/2021 MT Newswires(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...